about
Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsThe Promise of Preventive Cancer VaccinesCancer vaccines: state of the art of the computational modeling approachesTherapeutic cancer vaccines: past, present, and futureAnti-cancer vaccines - a one-hit wonder?Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaDesign of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitorDendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge.Vaccines, new opportunities for a new society.Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulatorSANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.Antigen release kinetics in the phagosome are critical to cross-presentation efficiencyA novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY.Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span.Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.CSPG4: a prototype oncoantigen for translational immunotherapy studies.Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrencePhase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402.Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis.Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro.Optimal vaccination schedule search using genetic algorithm over MPI technologyMesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.An autoimmune-mediated strategy for prophylactic breast cancer vaccination.Controversies in clinical cancer dormancyOncoantigens for an immune prevention of cancer.Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.Antitumor immunization of mothers delays tumor development in cancer-prone offspring.Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer.A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumorsWhole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma.Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.Spontaneous tumor rejection by cbl-b-deficient CD8+ T cellsThe FDA guidance on therapeutic cancer vaccines: the need for revision to include preventive cancer vaccines or for a new guidance dedicated to themPromises and limitations of murine models in the development of anticancer T-cell vaccines.Preclinical HER-2 Vaccines: From Rodent to Human HER-2Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune responsePotent tumor-specific protection ignited by adoptively transferred CD4+ T cells
P2860
Q26781538-B10B7FD8-AAED-4CFF-9FDF-FF74124B80CBQ26783742-7AEF743C-9665-4CB0-AA16-DBF14A885B3BQ26825044-EBC8468D-6415-4494-8A19-2B409BF18CCDQ26863283-7E537E69-8D80-4812-AA87-7231BC350214Q26995164-097CDFBE-256C-41D5-A4D2-A9F369A2C61EQ28069864-07D82A0E-0C47-47DD-B236-926C46B726CFQ28087470-3412CC37-1173-4744-8513-3935AE82DF3CQ28728165-E00B2DED-D78F-49E6-9E9A-5634627369E3Q30318566-BDE9F227-C833-422E-8AB4-9EE09D782E44Q30390904-3FFD93AC-43D9-408A-AE5B-6AEB103A82E1Q33251199-968E0EE3-258E-4FB0-B826-ADB890C2554CQ33578086-E7F039C5-8608-496C-8CCE-5E91C5792164Q33646495-F830C7C6-1126-4BDC-839C-91AA3CFF39F7Q33711774-5604EB21-781F-4F53-92B8-53923CC5B965Q33780089-62CEA3C7-B0F2-4115-8A0F-72BCEA8A3EAFQ33859814-730E8189-9C4F-49AE-96A0-06037A43A01BQ33862585-B9BA223E-A225-4006-9969-6854A604341CQ34072332-8F753A80-3ACA-4D4F-A119-75BE5B5E7283Q34173622-1AB984AE-C079-4568-9420-1A3E0A8C02C6Q34180316-1386D3E8-23C8-42CC-85F7-7FF7D7AA442DQ34241366-68FF16A1-3D34-4B24-ACB9-0F3DBBF1E1DDQ34329922-3E5205F9-8CD4-42A6-A023-0B8E7C23FB95Q34475889-51F8F9AA-1FE3-4A45-95FC-AC9996C3FE7EQ34847859-67CA983B-CB96-49A4-8CB9-59B81EAEEF3EQ34985115-748044DC-FE01-4499-AF2B-6952E2CD37ACQ35134139-E22C75F4-0902-438B-A333-BC0CE535D8C5Q35232253-5F2A55CF-8DC8-4F3B-B279-2E96429DE92AQ35710332-EB2F6452-72E6-44E1-BF6B-0C57FAC95E92Q35799346-374FBF04-856B-4638-9192-2CB102E7BDCCQ35851930-DA0A8F1B-1F80-440A-8AAE-A2CF49DCD160Q35918770-433A5DA7-D5E3-4A08-9923-094F8F6F7FF6Q36130491-F850A1BE-B255-4098-87F7-594CC3298F92Q36170378-EEB37B52-DD3C-47DD-BAFA-0BC58827F7AEQ36229277-55F82726-AC7A-4BE9-BC8E-53229E2EA6BBQ36248790-9F31D6F9-C225-46BF-ADA1-5FA2533158D1Q36684482-DFA3BAAB-D96C-43AE-B1D7-ABDA493FE7D0Q36914661-EF41EAFD-D1F1-4094-BB28-B18026FD91E9Q36918233-9B102970-C5B9-4C0D-B3D4-E90DFCEEABCCQ36945070-EBD57F7A-246B-4302-BCA9-4A65B3352165Q37000845-65D9FD69-44EC-4273-AEE7-A52F010E4F82
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Vaccines for tumour prevention
@ast
Vaccines for tumour prevention
@en
Vaccines for tumour prevention
@nl
type
label
Vaccines for tumour prevention
@ast
Vaccines for tumour prevention
@en
Vaccines for tumour prevention
@nl
prefLabel
Vaccines for tumour prevention
@ast
Vaccines for tumour prevention
@en
Vaccines for tumour prevention
@nl
P2860
P50
P3181
P356
P1476
Vaccines for tumour prevention
@en
P2093
Guido Forni
P2860
P2888
P304
P3181
P356
10.1038/NRC1815
P407
P577
2006-03-01T00:00:00Z
P6179
1016473468